Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Patrick Johnston

Hand Surgery Steamboat Springs, CO Doctor of Osteopathy

NPI 1073748653 CMS profile 1396895

705 Marketplace Plz, Steamboat Springs, CO 80487

Open in the dashboard

General payments

$4,710

52 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Patrick Johnston of Steamboat Springs, CO is reported in the CMS Open Payments database as having received $4,710 across 52 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 64th percentile of Hand Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $478 10
2024 General $102 5
2023 General $86 1
2022 General $2,246 8
2021 General $172 5
2020 General $176 5
2019 General $1,450 18

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Patrick Johnston
  • Hand Surgery median
  • Middle half of Hand Surgery
  • National median

In program year 2025, general payments to Patrick Johnston were reported at $478. Among 1,842 Hand Surgery profiles paid that year, the median was $270 and the middle half received between $102 and $1,118.

Show as a table
Year Patrick Johnston Hand Surgery median Middle half National median
2019 $1,450 $383 $106–$1,905 $163
2020 $176 $172 $51–$1,268 $114
2021 $172 $263 $71–$1,591 $132
2022 $2,246 $336 $87–$1,938 $149
2023 $86 $233 $81–$1,114 $160
2024 $102 $258 $88–$1,203 $164
2025 $478 $270 $102–$1,118 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Arthrex, Inc. $1,313 3 payments
  2. AxoGen $1,225 7 payments
  3. Acumed LLC $1,169 11 payments
  4. Stryker Corporation $301 4 payments
  5. Endo Pharmaceuticals Inc. $246 14 payments
  6. IlluminOss Medical, Inc. $115 1 payment
  7. Trice Medical, Inc. $107 1 payment
  8. Bioventus LLC $66 3 payments
  9. Endo USA, Inc. $57 3 payments
  10. Ossur Americas., Inc $43 2 payments
  11. Other $67 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $2,452 48 payments
  2. Education $1,200 1 payment
  3. Travel and Lodging $1,057 3 payments
Products named General payments · program years 2019–2025
  1. Avance Nerve Graft $987 4 payments
  2. Anatomic Radial Head System $910 5 payments
  3. Acu-Loc Wrist Plating System $850 6 payments
  4. Elbow Plating System $727 3 payments
  5. Hand Fracture System $647 1 payment
  6. Total Wrist Fusion Plating System $647 1 payment
  7. XIAFLEX $303 17 payments
  8. Acutrak Headless Compression Screw System $244 3 payments
  9. Acu-Loc Wrist Spanning System $152 2 payments
  10. TRAUMA $122 1 payment
  11. Other $909 19 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 107 billing codes

Paid by Medicare

$118,070

Of which drugs: $15,666

Medicare patients

260

Average age 73

Services billed

1,540

123 women, 137 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 62%
High blood pressure 48%
Cancer 16%
Ischemic heart disease 15%
Depression 13%
Osteoporosis 13%
Chronic kidney disease 9%
Diabetes 8%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 32 87 $472
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 49 198 $138

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
XIAFLEX
  • Endo Pharmaceuticals Inc. $15
  • Endo USA, Inc. $15
$31 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

52 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Hand Surgery in Colorado

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record